COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=49664

Chen Hong

chenhong1129@hotmail.com

2020-02-17

Recruiting

RCT

Randomized

Parallel

Not reported

single-center

Treatment

(1) Aged 18-65 years, (2) Virus nucleic acid test is positive, (3) Lung CT showed multiple patchy, lumpy ground glass opacity(GGO), consolidation or other typical manifestations in both lungs .

(1) Positive for other pathogens such as A, B, Mycoplasma, Adenovirus, (2) patients require mechanical ventilation, (3) People with metal or pacemaker, (4) active tuberculosis, (5) Massive pulmonary fibrosis, (6) Those with shock, (7) Those who have bleeding tendency or active bleeding in the lungs, (8) Patients with multiple organ failure who need ICU monitoring and treatment, (9) Patients with tumor and severe basic diseases, (10) pregnant or lactating women, (11) Patients with active tuberculosis, (12) Those with other contraindications to ultrashort wave, (13) Patients with severe cognitive impairment who cannot follow the instructions to complete the treatment, (14) Those without signed informed consent, (15) Researchers believe that other reasons are not suitable for clinical trials.

2

Tongji Hospital; Tongji Medical College;Huazhong University of Science and Technology

18

65

China

Moderate/severe disease at enrollment

4: Moderate/severe disease at enrollment

40

the rate of Coronary virus nucleic acid negative at 7 days; 14 days; 21 days; and 28 days after Ultra Short Wave Electrotherapy;systemic inflammatory response syndrome (SIRS) scores at 7 days; 14 days; 21 days; and 28 days after Ultra Short Wave Electrotherapy;

| Declared number of arm (2.0) differs from found arms (3.0)

Not reported

[{"arm_notes": "", "treatment_id": 1331, "treatment_name": "Ultra short wave electrotherapy", "treatment_type": "Medical device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]